期刊文献+

丙丁酚对oxLDL诱导血管内皮细胞增殖抑制的保护作用

Protective effect of probucol on oxLDL-induced inhibition of HUVEC cell proliferation
原文传递
导出
摘要 目的:探讨丙丁酚(普罗布考)对氧化低密度脂蛋白(oxLDL)诱导人脐静脉血管内皮细胞(HUVEC)损伤的保护作用,以及对NF-κB和IκB-α表达的调节作用。方法:MTT法分别检测oxLDL不同浓度(1g/ml、10g/ml、100g/ml)处理HUVEC不同时间(12h、24h、48h)细胞增殖情况;5g/mL丙丁酚预处理HUVEC24小时,MTT检测细胞增殖情况;Western blot检测oxLDL处理细胞及丙丁酚预处理后NF-κB和IκB-α蛋白表达水平。结果:oxLDL处理HUVEC细胞24小时后,对细胞增殖具有抑制作用,Western blot结果显示NF-κB表达显著上调,IκB-α蛋白表达下调。而用5ug/mL丙丁酚预处理可以明显缓解细胞增殖抑制,NF-κB和IκB-α蛋白的表达也恢复至正常水平。结论:丙丁酚可显著缓解oxLDL诱导的HUVEC细胞增殖抑制,并且NF-κB和IκB-α表达的改变可能参与此过程。 Objective:To investigate the protect of oxLDL on oxLDL-induced inhibition of HUVEC cell proliferation, and explore the regulation of NF-κB and IκB-α.Methods:Pretreated the HUVEC with probucol in different dose (1 g/mL, 10 g/mL, 100 g/mL) and time(12h, 24h, 48h), and proliferation of cells were examined by MTT;then 5 g/mL probucol pretreated the HUVEC for24h, MTT method measured the proliferation of cells.NF-κB and IκB-α protein were measured by Western blotting after treated with probucol.Results:The cell proliferation was significantly inhibited when treated with probucol.The result of Western blotting showed that NF-κB was down-regulated, IκB-α was up-regulated.While 5ug/mL probucol pretreated the HUVEC, the inhibiation of proliferation relieved, and the expression of NF-κB and IκB-α returned to normal levels.Conclusions:Probucol significantly relieve the oxLDL-induced inhibition of HUVEC cell proliferation, and the alterant expression of NF-κB and IκB-α may be involved in this process.
出处 《现代生物医学进展》 CAS 2010年第15期2918-2920,2934,共4页 Progress in Modern Biomedicine
关键词 丙丁酚 NF-ΚB 细胞增殖 probucol NF-κB cell proliferation
  • 相关文献

参考文献3

二级参考文献24

  • 1廖端芳,陈剑雄,黄红林,唐小卿,曹建国,余麟.丙丁酚对自由基损伤内皮细胞的保护作用与一氧化氮的关系[J].中国动脉硬化杂志,1994,2(2):67-71. 被引量:9
  • 2杨映波 王正国 等.一种分离循环内皮细胞的新方法[J].中国药理学与毒理学杂志,1994,8(1):29-29.
  • 3Szekanecz Z, Koch AE. Endothelial cel.Ls in inflammation and angiogenesis. Curt Drug Targets Inflamn Allergy,2005,4: 319-323.
  • 4Bing h, Wang J, Zhang C. et al. Positive correlation between in vivo oxidized LDL and LDL immune complex. Clin Biochem,2004,37:72-75.
  • 5Yokoyama T, Miyauchi K, Kurata B, et al. Effect of probucol on neointimal thickening in a stent porcine restenosis model. Jpn Heart J, 2004, 45: 305-313.
  • 6Celemajer DS, Sorensen KE, Gooch VM, et al. Non-in-vasive detection of endothelial dysfunction in children and adults atrisk of atherosclerosis. Lancet, 1992,340 : 1111-1115.
  • 7Anderson TJ, Roberts AC, Hildebrand K, et al. The fate of endothelial function testing: rationale and design of the Firefighters And Their Endothelium (FATE) study. Can J Cardiol, 2003,19:61-66.
  • 8Goldstein JL, Brown MS. Molecular medicine: the cholesterol quartet. Science, 2001 292:1310-1312.
  • 9Matsumoto N, Nomura S, Kamihata H, et al. Increased level of oxidized, LDL-dependent monocyte-defived microparticled in acute coronary syndrome. Thromb Heamost,2004,91:146-154.
  • 10Asmis R, Begley JG, Jelk J, et al. Lipoprotein aggregation protects human monocyte-derived macrophages from OxLDL-induced cytotoxicity. Lipid Res,2005,46 : 1124-1132.

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部